Sergliflozin A

SKU: orb1819133

Description

Sergliflozin A is a potent and selective SGLT2 inhibitor used in diabetes research. It demonstrates a dose-dependent induction of diabetic phenotypes while effectively lowering blood glucose levels in experimental models. This compound is a valuable tool for in vitro and in vivo studies of glucose metabolism and SGLT2 function.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 360775-96-8
• MW: 376.4
• Purity: 99.71% (May vary between batches)
• Formula: C₂₀H₂₄O₇
• SMILES: O(C1=C(CC2=CC=C(OC)C=C2)C=CC=C1)[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O
• Target: SGLT
• Solubility: DMSO:38.46 mg/mL (102.18 mM)

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

SGLT2

Compound Identifiers

PubChem CID

10177526